Document 0233 DOCN M9650233 TI Generation of human T lymphocytes from bone marrow CD34+ cells in vitro. DT 9605 AU Freedman AR; Zhu H; Levine JD; Kalams S; Scadden DT; Division of Hematology/Oncology, New England Deaconess Hospital,; Harvard Medical School, Boston, Massachusetts 02129, USA. SO Nat Med. 1996 Jan;2(1):46-51. Unique Identifier : AIDSLINE MED/96135164 AB Analysis of the events that regulate development of red blood cells or granulocytes has led to therapies altering clinical conditions associated with anemia or neutropenia. The development of therapeutic approaches to target conditions associated with lymphopenia, such as AIDS, has been thwarted by limited techniques for studying T-lymphocyte development. We describe an in vitro system in which human bone marrow CD34+ cells proliferate, acquire the expression of the lymphoid-specific RAG-2 gene and a broad repertoire of rearranged T-cell receptor genes, develop the ability to produce T cell-specific interleukin-2 and achieve a range of T-cell immunophenotypes. The cells also become susceptible to infection with the T-lymphotropic strain of human immunodeficiency virus-1, HIV-1IIIB. This culture system induces human T lymphopoiesis and may permit further analysis of the events regulating human T-lineage differentiation. It provides a preclinical model for screening stem cell gene therapies directed toward AIDS. DE Adult Antigens, CD *Antigens, CD34 Base Sequence Bone Marrow/*CYTOLOGY/*IMMUNOLOGY Cells, Cultured DNA Primers Fetus Flow Cytometry Gene Expression Hematopoietic Stem Cells/CYTOLOGY/IMMUNOLOGY Human HIV-1/*PHYSIOLOGY/PATHOGENICITY Immunophenotyping Interleukin-2/BIOSYNTHESIS Molecular Sequence Data Polymerase Chain Reaction Proteins/BIOSYNTHESIS Receptors, Antigen, T-Cell, alpha-beta/GENETICS Stromal Cells/CYTOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. T-Lymphocytes/CYTOLOGY/*IMMUNOLOGY/VIROLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).